Mon. Jan 30th, 2023

Mumbai (Maharashtra) [India], October 22: Shree Ramkrishna Netralaya is pleased to bring istent, and istent inject by Glaukos, the USA for the first time in India. This is the world’s smallest medical device known to be implanted in the human body.

Glaucoma, a sneak thief of sight that Affects 3 in every 100 people across the globe. Glaucoma genes are passed from one generation to another. These altered genes change the constitution of the trabecular meshwork, an area in the front part of the eye through which fluid inside the eye can flow out. This causes blockage of water (aqueous humor) inside the eye, which leads to raised pressure inside the eye, causing damage to the optic nerve.

Dr. Nitin Deshpande of Shree Ramkrishna Netralaya, on the occasion of launch functions, said, “Glaucoma being the 3rd largest cause of blindness in India, with almost 12 million diagnosed patients, we in Shree Ramakrishna Eye Hospital, is committed towards adopting the latest innovation in the field of glaucoma, to ensure world-class patient management and preserving vision till death.”

He further said that “iStent & iStent inject, the latest global innovation by Glaukos Corporation, USA, has been implanted in 3 patients for the first time in India, in our institute. It’s a micro-invasive glaucoma surgery procedure, which not only helps in managing glaucoma effectively and safely but also helps in fighting the key issue of non-adherence to current medication (eye drops), the key reason for glaucoma progression in 53% of treated patients. Since glaucoma is asymptomatic, the damage is already advanced once the patient realizes that he has visual problems.

Once this device is entangled in trabecular meshwork by a skilled surgeon, it increases the outflow of eye fluid (aqueous Humor) which restores the balance of pressure inside the eye, preventing further damage to the Optic Nerve.”

There are multiple advantages to this new generation of glaucoma surgery:

  • It can be inserted through micro-incision, there is minimal injury to the eye
  • This device can be implanted during routine cataract surgery, preventing the need for additional cuts
  • The use of surgical grade titanium and a proven track record makes this surgery safe for the eye.

Shree Ramkrishna Netralaya is a recipient of the prestigious full NABH accredited eye institute in Thane, Mulund and Navi Mumbai. Its well-equipped glaucoma department is providing world-class Glaucoma care at an affordable cost for over 15 years. We are committed to providing compassionate eye care to all under one roof.

By dsprime

9 thoughts on “Advanced Micro Incision Glaucoma Surgery (istent) For the First Time in India at Shree Ramkrishna Netralaya, Thane, Mumbai and Navi Mumbai”
  1. 960809 113601I simply could not go away your site prior to suggesting that I actually enjoyed the normal info an individual supply to your visitors? Is gonna be once again continuously in order to look at new posts 697330

  2. 616939 793263We are a group of volunteers and opening a new system in our community. Your web internet site given us with valuable details to function on. Youve done an impressive job and our entire community will be grateful to you. 103164

  3. 771783 31645I believe other internet site owners really should take this internet site as an example , very clean and wonderful user genial style . 834525

  4. 441899 180727We dont trust this amazing submit. Nevertheless, I saw it gazed for Digg along with Ive determined you could be appropriate so i ended up being imagining within the completely wrong way. Persist with writing top quality stuff along these lines. 865524

  5. 238258 437944I real delighted to discover this website on bing, just what I was looking for : D also bookmarked . 128406

  6. 354652 661922I havent checked in here for some time because I thought it was finding boring, but the last few posts are really good quality so I guess Ill add you back to my daily bloglist. You deserve it my friend. insurance guides 129503

Leave a Reply

Your email address will not be published.